Chinese herbs of Shenghe Powder reverse multidrug resistance of gastric carcinoma SGC-7901.

The objective of this study was to investigate the reversal effect of Chinese herbs of Shenghe Powder on the multidrug resistance of the human SGC-7901 gastric carcinoma cell line and vincristine-resistant cell line (SGC-7901/vincristine) and the possible mechanism. SGC-7901 and SGC-7901/ vincristine were cultured in liquid medium RMPI 1640, with the addition of vincristine to the vincristine-resistant line. The reversal effect of Shenghe Powder (using verapamil as control) on the multidrug resistance of SGC-7901/vincristine cells was observed using the 3-4,5-dimethylthiazol-2yl) -2,5-diphenylterazolium bromide method. The expression rate of P-glycoprotein (P-gp), lymphoma/leukemia-2 (Bcl-2), and apoptosis ratio of SGC-7901 and SGC-7901/vincristine with added Shenghe Powder, verapamil, or verapamil plus Shenghe Powder was observed by flow cytometry. Shenghe Powder and verapamil decreased the multidrug resistance of SGC-7901/vincristine. The effect of Shenghe Powder (10 mg/L) was significantly higher than verapamil (P< .05). The intracellular concentration of vincristine was increased by Shenghe Powder and verapamil. The vincristine concentration of SGC-7901/vincristine treated with Shenghe Powder was significantly higher (P< .05). Shenghe Powder reduced the expression level of P-gp and Bcl-2 in SGC-7901/ vincristine and increased the apoptotic percentage of tumor cells; Shenghe Powder had the more significant effect on apoptosis (P< .05). In conclusion, Shenghe Powder increases the intracellular concentration of vincristine, consistent with the down-regulation of the expression of P-gp and Bcl-2. The reversal effect of Shenghe Powder was stronger than that of verapamil.

[1]  R. O'connor,et al.  The pharmacology of cancer resistance. , 2007, Anticancer research.

[2]  S. Raguz,et al.  Ability to acquire drug resistance arises early during the tumorigenesis process. , 2007, Cancer research.

[3]  R. Kiwan,et al.  Antitumor activity of new liposomal prodrug of mitomycin C in multidrug resistant solid tumor: Insights of the mechanism of action , 2007, Journal of drug targeting.

[4]  N E Day,et al.  Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions. , 2006, Carcinogenesis.

[5]  E. Mini,et al.  Pharmacological strategies for overcoming multidrug resistance. , 2006, Current drug targets.

[6]  H. Lage.  MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance. , 2006, Current drug targets.

[7]  T. Ozben.  Mechanisms and strategies to overcome multiple drug resistance in cancer , 2006, FEBS letters.

[8]  B. Zhu,et al.  Chemosensitizing multiple drug resistance of human carcinoma by bicyclol involves attenuated P-glycoprotein, GST-P and Bcl-2 , 2006, Cancer biology & therapy.

[9]  Xiang-rong Song,et al.  [Research progress in the reversion of traditional Chinese medicine on multidrug resistance of tumor]. , 2005, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[10]  Penny A. Johnson,et al.  Cancer cell adaptation to chemotherapy , 2005, BMC Cancer.

[11]  Zhenwu Du,et al.  Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors. , 2005, Chinese medical journal.

[12]  P. Sonneveld,et al.  Identification of multidrug resistance‐associated protein 1 and glutathione as multidrug resistance mechanisms in human prostate cancer cells: chemosensitization with leukotriene D4 antagonists and buthionine sulfoximine , 2004, BJU international.

[13]  Wang Huan.  Inducing Differentiation Effect of Shenghe Powder on C6 Brain Glioma Cells , 2007 .

[14]  Gaoshen,et al.  Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors , 2005 .

[15]  Maria-José U. Ferreira,et al.  Rearranged jatrophane-type diterpenes from euphorbia species. Evaluation of their effects on the reversal of multidrug resistance. , 2004, Planta medica.

[16]  Xia Yue-sheng.  Clinical Study on Treating Liver Metastases from Digestive Tract Cancer with Shenghe Powder Combined with Interventional Therapy , 2001 .